IPSC Competitors & Alternatives
Compare Century Therapeutics Inc with similar stocks in the same industry
Biotechnology
IPSC
Main Stock$1.58
Tradestie Score
33
Market Cap
$43.18M
Revenue Growth
-1.0%
Analyst Upside
+200.6%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANNX
Annexon, Inc. Common Stock
|
$3.81
|
$332.96M | - | 52 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.99
|
$328.62M | - | 51 | Compare |
|
LYEL
Lyell Immunopharma, Inc. Common Stock
|
$9.38
|
$317.95M | - | 50 | Compare |
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$7.59
|
$307.12M | - | 61 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.38
|
$304.12M | - | 60 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$14.91
|
$297.23M | - | 50 | Compare |
|
OMER
Omeros Corporation
|
$16.86
|
$281.75M | 13.6 | 60 | Compare |
|
DBVT
DBV Technologies S.A.
|
$9.68
|
$275.54M | - | 61 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$18.94
|
$269.08M | 0.1 | 64 | Compare |
|
PBYI
PUMA BIOTECHNOLOGY INC
|
$11.26
|
$265.45M | 21.1 | 39 | Compare |
More IPSC Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2836)
222 stocks in this industry